Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)

A. Sinicrope Frank, Qian Shi, Fabienne Hermitte, Erica Heying, B. Benson Al, Sharlene Gill, M. Goldberg Richard, Morton Kahlenberg, Suresh Nair, Anthony Shields, Dan Sargent, Jérôme Galon, R. Alberts Steven

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)iii153
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume28
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this